Citadel Advisors »

Mirati Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $7.7M 131k 58.75
2023-09-30 $54M 1.2M 43.56
2023-06-30 $20M 550k 36.13
2023-03-31 $6.3M 170k 37.18
2022-12-31 $19M 408k 45.31
2022-06-30 $15M 224k 67.11
2022-03-31 $8.3M 101k 82.24
2021-12-31 $33M 228k 146.70
2021-09-30 $52M 294k 176.91
2021-06-30 $92M 568k 161.53
2021-03-31 $98M 569k 171.30
2020-12-31 $77M 351k 219.64
2020-09-30 $34M 189k 181.82
2020-06-30 $25M 180k 136.36
2020-03-31 $24M 306k 78.95
2019-12-31 $56M 436k 128.86
2019-09-30 $69M 892k 77.59
2019-06-30 $78M 755k 102.76
2019-03-31 $7.1M 98k 72.40
2018-12-31 $1.9M 44k 42.41
2018-09-30 $5.8M 124k 47.09
2018-06-30 $1.8M 36k 49.30
2018-03-31 $1.5M 49k 30.71
2017-12-31 $548k 30k 18.24
2017-09-30 $268k 23k 11.71
2016-09-30 $109k 17k 6.61
2016-06-30 $120k 22k 5.44
2016-03-31 $274k 13k 21.40
2015-12-31 $978k 31k 31.62
2015-09-30 $4.2M 122k 34.21